Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 6,418,000 $ 1,079,000
Restricted cash 93,000
Short-term investments 12,893,000
Prepaid expenses and other current assets 248,000 84,000
Total Current Assets 6,759,000 14,056,000
Operating lease right-of-use asset 53,000
TOTAL ASSETS 6,759,000 14,109,000
Current liabilities    
Accounts payable 2,612,000 4,328,000
Accrued expenses 1,868,000 1,195,000
Current operating lease liability 58,000
Warrant liability 182,000 1,052,000
Total Current Liabilities 4,662,000 6,633,000
Stockholders’ Equity    
Convertible Preferred stock, par value $0.01, 15,000,000 shares authorized Series C - 96,230 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 1,000 1,000
Common stock, par value $0.001, 250,000,000 shares authorized, 2,234,328 and 1,380,633 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 2,000 1,000
Additional paid in capital 693,546,000 689,539,000
Accumulated deficit (691,452,000) (682,065,000)
Total Stockholders’ Equity 2,097,000 7,476,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 6,759,000 $ 14,109,000